Top

Published in:

Open Access 01-12-2014 | Review

Innate lymphoid cells and the skin

Authors: Maryam Salimi, Graham Ogg

Published in: BMC Dermatology | Issue 1/2014

Abstract

Innate lymphoid cells are an emerging family of effector cells that contribute to lymphoid organogenesis, metabolism, tissue remodelling and protection against infections. They maintain homeostatic immunity at barrier surfaces such as lung, skin and gut (Nature 464:1367–1371, 2010, Nat Rev Immunol 13: 145–149, 2013). Several human and mouse studies suggest a role for innate lymphoid cells in inflammatory skin conditions including atopic eczema and psoriasis. Here we review the innate lymphoid cell family and discuss their function in the skin and during inflammation.

Available only for authorised users

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E: Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13(2):145–149. 10.1038/nri3365CrossRefPubMed

Neill DR, Wong H, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane CM, Fallon PJ, Pannell R, Jolin HE, McKenzie AN: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464: 1367–1371. 10.1038/nature08900CrossRefPubMedPubMedCentral

Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F: Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464(7293):1371–1375. 10.1038/nature08949CrossRefPubMedPubMedCentral

Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G: Lineage relationship analysis of RORgammat + innate lymphoid cells. Science 2010, 330(6004):665–669. 10.1126/science.1194597CrossRefPubMed

Spits H, Cupedo T: Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012, 30: 647–675. 10.1146/annurev-immunol-020711-075053CrossRefPubMed

Constantinides MG, McDonald BD, Verhoef PA, Bendelac A: A committed precursor to innate lymphoid cells. Nature 2014, 508(7496):397–401. 10.1038/nature13047CrossRefPubMedPubMedCentral

Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331(6013):44–49. 10.1126/science.1198687CrossRefPubMedPubMedCentral

Kiessling R, Klein E, Pross H, Wigzell H: “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975, 5(2):117–121. 10.1002/eji.1830050209CrossRefPubMed

Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjosberg JM, Spits H: Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013, 14(3):221–229. 10.1038/ni.2534CrossRefPubMed

10.

Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC, Lindsten T, Reiner SL: The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012, 36(1):55–67. 10.1016/j.immuni.2011.11.016CrossRefPubMedPubMedCentral

11.

Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M: Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 2013, 38(4):769–781. 10.1016/j.immuni.2013.02.010CrossRefPubMedPubMedCentral

12.

Brusselle GG, Joos GF, Bracke KR: New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011, 378(9795):1015–1026. 10.1016/S0140-6736(11)60988-4CrossRefPubMed

13.

Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Holscher C, Honig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A: Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010, 33(5):736–751. 10.1016/j.immuni.2010.10.017CrossRefPubMedPubMedCentral

14.

Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM: Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 2010, 107(25):11489–11494. 10.1073/pnas.1003988107CrossRefPubMedPubMedCentral

15.

Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S: Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463(7280):540–544. 10.1038/nature08636CrossRefPubMed

16.

Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T, Bhandoola A, Artis D: IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 2010, 464: 1362–1366. 10.1038/nature08901CrossRefPubMedPubMedCentral

17.

Saenz SA, Siracusa MC, Monticelli LA, Ziegler CG, Kim BS, Brestoff JR, Peterson LW, Wherry EJ, Goldrath AW, Bhandoola A, Artis D: IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J Exp Med 2013, 210(9):1823–1837. 10.1084/jem.20122332CrossRefPubMedPubMedCentral

18.

Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D: Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12(11):1045–1054. 10.1038/ni.2131CrossRefPubMedPubMedCentral

19.

Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H: Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12(11):1055–1062. 10.1038/ni.2104CrossRefPubMed

20.

Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, Mitchell AJ, Tay SS, Jain R, Forbes-Blom E, Chen X, Tong PL, Bolton HA, Artis D, Paul WE, Fazekas de St Groth B, Grimbaldeston MA, Le Gros G, Weninger W: Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 2013, 14(6):564–573. 10.1038/ni.2584CrossRefPubMedPubMedCentral

21.

Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong H, Cruickshank JP, McKenzie AN: Innate IL-13–producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 2012, 129(1):191–198. 10.1016/j.jaci.2011.09.041CrossRefPubMed

22.

Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, Englezakis A, Barlow JL, Hams E, Scanlon ST, Ogg GS, Fallon PG, McKenzie AN: MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014, 41(2):283–295. 10.1016/j.immuni.2014.06.016CrossRefPubMedPubMedCentral

23.

Mirchandani AS, Besnard AG, Yip E, Scott C, Bain CC, Cerovic V, Salmond RJ, Liew FY: Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J Immunol 2014, 192(5):2442–2448. 10.4049/jimmunol.1300974CrossRefPubMed

24.

Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E: Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009, 10(1):75–82. 10.1038/ni.1681CrossRefPubMed

25.

Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O’Shea JJ: Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206(1):35–41. 10.1084/jem.20072713CrossRefPubMedPubMedCentral

26.

Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H: Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10(1):66–74. 10.1038/ni.1668CrossRefPubMed

27.

Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, Itoh K, Littman DR, Fagarasan S: Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008, 29(2):261–271. 10.1016/j.immuni.2008.05.014CrossRefPubMed

28.

Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP: Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29(6):958–970. 10.1016/j.immuni.2008.11.001CrossRefPubMed

29.

Satpathy AT, Briseno CG, Lee JS, Ng D, Manieri NA, Kc W, Wu X, Thomas SR, Lee WL, Turkoz M, McDonald KG, Meredith MM, Song C, Guidos CJ, Newberry RD, Ouyang W, Murphy TL, Stappenbeck TS, Gommerman JL, Nussenzweig MC, Colonna M, Kopan R, Murphy KM: Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol 2013, 14(9):937–948. 10.1038/ni.2679CrossRefPubMedPubMedCentral

30.

Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Berard M, Kleinschek M, Cua D, Di Santo JP, Eberl G: RORgammat + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011, 12(4):320–326. 10.1038/ni.2002CrossRefPubMed

31.

Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grunberg S, Sinha R, Mantegazza AR, Ma HL, Crawford A, Angelosanto JM, Wherry EJ, Koni PA, Bushman FD, Elson CO, Eberl G, Artis D, Sonnenberg GF: Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013, 498(7452):113–117. 10.1038/nature12240CrossRefPubMedPubMedCentral

32.

Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, Radtke F, Hardman CS, Hwang YY, Fallon PG, McKenzie AN: Transcription factor RORα is critical for nuocyte development. Nat Immunol 2012, 13(3):229–236. 10.1038/ni.2208CrossRefPubMedPubMedCentral

33.

Yang Q, Monticelli LA, Saenz SA, Chi AW, Sonnenberg GF, Tang J, De Obaldia ME, Bailis W, Bryson JL, Toscano K, Huang J, Haczku A, Pear WS, Artis D, Bhandoola A: T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 2013, 38(4):694–704. 10.1016/j.immuni.2012.12.003CrossRefPubMedPubMedCentral

34.

Klein Wolterink RG, Serafini N, van Nimwegen M, Vosshenrich CA, de Bruijn MJ, Fonseca Pereira D, Veiga Fernandes H, Hendriks RW, Di Santo JP: Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc Natl Acad Sci U S A 2013, 110(25):10240–10245. 10.1073/pnas.1217158110CrossRefPubMedPubMedCentral

35.

Furusawa J, Moro K, Motomura Y, Okamoto K, Zhu J, Takayanagi H, Kubo M, Koyasu S: Critical role of p38 and GATA3 in natural helper cell function. J Immunol 2013, 191(4):1818–1826. 10.4049/jimmunol.1300379CrossRefPubMedPubMedCentral

36.

Mjösberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H: The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012, 37(4):649–659. 10.1016/j.immuni.2012.08.015CrossRefPubMed

37.

Doherty TA, Khorram N, Chang JE, Kim HK, Rosenthal P, Croft M, Broide DH: STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. Am J Physiol Lung Cell Mol Physiol 2012, 303(7):L577-L588. 10.1152/ajplung.00174.2012CrossRefPubMedPubMedCentral

38.

Yang Q, Saenz SA, Zlotoff DA, Artis D, Bhandoola A: Cutting edge: natural helper cells derive from lymphoid progenitors. J Immunol 2011, 187(11):5505–5509. 10.4049/jimmunol.1102039CrossRefPubMedPubMedCentral

39.

Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN, Fallon PG, Ogg GS: A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013, 210(13):2939–2950. 10.1084/jem.20130351CrossRefPubMedPubMedCentral

40.

Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H, Klenerman P, Ogg G: Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 2014, 133(4):1184–1194. 10.1016/j.jaci.2013.10.056CrossRefPubMedPubMedCentral

41.

Teunissen MB, Munneke JM, Bernink JH, Spuls PI, Res PC, Te Velde A, Cheuk S, Brouwer MW, Menting SP, Eidsmo L, Spits H, Hazenberg MD, Mjosberg J: Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014, 134(9):2351–2360. 10.1038/jid.2014.146CrossRefPubMed

42.

Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D: TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013, 5(170):170ra116.CrossRef

43.

Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD: Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 2013, 5(174):174ra126.CrossRef

44.

Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004, 113(5):651–657. 10.1172/JCI21060CrossRefPubMedPubMedCentral

45.

Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, Nakanishi K, Yamanishi K: Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 2013, 110(34):13921–13926. 10.1073/pnas.1307321110CrossRefPubMedPubMedCentral

46.

Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, Chapman A, Smith CH, Di Meglio P, Nestle FO: Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 2014, 134(4):984–991. 10.1038/jid.2013.477CrossRefPubMed

47.

Dyring-Andersen B, Geisler C, Agerbeck C, Lauritsen JP, Gudjonsdottir SD, Skov L, Bonefeld CM: Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol 2014, 170(3):609–616. 10.1111/bjd.12658CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-5945/14/18/prepub

Title: Innate lymphoid cells and the skin
Authors: Maryam Salimi
Graham Ogg
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Dermatology / Issue 1/2014
Electronic ISSN: 1471-5945
DOI: https://doi.org/10.1186/1471-5945-14-18

ACC 2024 Congress

Springer Medicine

Innate lymphoid cells and the skin

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Low rate of dermatology outpatient visits in Asian-Americans: an initial survey study for associated patient-related factors

Comparison of publication trends in dermatology among Japan, South Korea and Mainland China

A systematic literature review of pediculosis due to head lice in the Pacific Island Countries and Territories: what country specific research on head lice is needed?

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment

Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report